analyst
LE
NASDAQ · LENZ
LENZ Therapeutics, Inc.
Healthcare · Biotechnology
$3.30
Down-$0.11 (-3.33%)
Updated Oct 21, 2026, 12:48 AM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 684.09M
- P/E ratio
- -13.13
- Dividend yield
- 0.00%
- 52-week range
- $3.21 – $32.92
- Volume
- 648.61K
- Avg. volume
- 997.98K
Price performance · LENZ
LENZ price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 19, 2026
LENZ closed at $3.30 after 20 trading sessions, down 20.10% for the selected period.
- Last close
- $3.30
- Period change
- -20.10%
- Period low
- $3.27
- Period high
- $4.13
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | $3.27 | $3.40 | $3.209 | $3.30 | 648.61K |
| Oct 16, 2026 | $3.56 | $3.56 | $3.21 | $3.27 | 939.08K |
| Oct 15, 2026 | $3.43 | $3.64 | $3.43 | $3.57 | 793.85K |
| Oct 14, 2026 | $3.39 | $3.615 | $3.345 | $3.43 | 1.04M |
| Oct 13, 2026 | $3.62 | $3.62 | $3.395 | $3.40 | 605.46K |
| Oct 12, 2026 | $3.64 | $3.71 | $3.60 | $3.61 | 603.48K |
| Oct 9, 2026 | $3.53 | $3.65 | $3.42 | $3.645 | 625.76K |
| Oct 8, 2026 | $3.58 | $3.61 | $3.35 | $3.53 | 1.04M |
| Oct 7, 2026 | $3.72 | $3.72 | $3.58 | $3.62 | 515.5K |
| Oct 6, 2026 | $3.60 | $3.84 | $3.60 | $3.79 | 682.82K |
| Oct 5, 2026 | $3.60 | $3.60 | $3.455 | $3.59 | 777.42K |
| Oct 2, 2026 | $3.84 | $3.84 | $3.51 | $3.58 | 1.13M |
| Oct 1, 2026 | $3.85 | $3.91 | $3.79 | $3.79 | 738.9K |
| Sep 30, 2026 | $3.90 | $3.90 | $3.75 | $3.84 | 786.21K |
| Sep 29, 2026 | $3.96 | $3.97 | $3.79 | $3.86 | 645.15K |
| Sep 28, 2026 | $3.89 | $3.995 | $3.68 | $3.96 | 712.7K |
| Sep 25, 2026 | $3.75 | $4.00 | $3.66 | $3.915 | 923.82K |
| Sep 24, 2026 | $3.75 | $3.75 | $3.595 | $3.72 | 1.01M |
| Sep 23, 2026 | $4.14 | $4.14 | $3.735 | $3.76 | 765.64K |
| Sep 22, 2026 | $4.10 | $4.175 | $4.07 | $4.13 | 511.02K |
Latest LENZ news
The latest Smart Investors Daily articles mentioning LENZ.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…

